Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94) 1

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2815-2822

  Eccles, Suzanne A ^a   Box, Gary M ^a   Court, William J ^a   Bone, Elisabeth A ^b   Thomas, Wayne ^b   Brown, Peter D ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; LONG TERM CARE; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GELATINASES; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEOPLASM METASTASIS; PHENYLALANINE; RATS; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL RATE; THIOPHENES;

EID: 0029934985     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Matrisian, L. M. The matrix degrading metalloproteinases Bioessays, 14: 455-462, 1992
2. Kleiner, D. E., and Stetler-Stevenson, W. G. Structural biochemistry and activation of matrix metalloproteinases Curr. Opin. Cell Biol., 5: 891-897, 1993.
3. Cottam D. W., and Rees, R. C. Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int. J. Oncol., 2: 861-872, 1993.
4. Chirivi, R. G. S , Garofalo, A., Crimmin, M. J., Bawden, L. J., Stoppacciaro, A., Brown, P. D., and Giavazzi, R. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int. J. Cancer, 58: 460-464, 1994.
5. Alvarez, O A., Carmichael, D F , and DeClerck, Y. A Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst., 82: 589-595, 1990
6. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52: 701-708, 1992
7. Ray, J. M., and Stetler-Stevenson, W. G The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J., 7: 2062-2072, 1994.
8. Daidone, M. G., Silvestrum, R., D'Errico, A. D., Di Fronzo, G., Benini, E., Mancini, A. M , Garbisa, S., Liotta, L A., and Grigioni, W. F. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int. J Cancer. 48: 529-532, 1991.
9. Brown, P. D., Bloxidge, R. E., Anderson, E., and Howell, A Expression of activated gelatinase in human invasive breast cancer. Clin Exp. Metastasis, 11: 183-189, 1993
10. Davies, B., Miles, D W., Happerfield, M. L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D , and Balkwill, F. R. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67: 1126-1131, 1993.
11. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53: 140-146, 1993
12. Visscher, D. W., Hoyhtya, M. Ottosen, S K., Liang, C-M , Sarkar, F. H , Crissman, J. D , and Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence Int. J. Cancer, 59; 339-344, 1994.
13. Stetler-Stevenson, W G , Liotta, L. A., and Brown, P D The role of metalloproteinases in breast cancer In. R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, pp 21-41. Boston. Kluwer Academic Publishers, 1991
14. Eccles, S. A., Box, G , Court, W., Sandle, J , and Dean, C. J. Preclinical models for the evaluation of targeted therapies of metastatic disease Cell Biophys , 24/25: 279-291, 1994.
15. Young, H., Carnochan, P., Trivedi, M., Potter, G. A., Eccles, S. A., Haynes, B. P , Jarman, M , and Ott, R. J. Pharmacokinetics and biodistribution of radiolabelled Idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy. Nucl. Med Biol , 22, 405-411, 1995
16. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50: 6184-6191, 1990
17. 14C] acetylated collagen. Anal. Biochem., 99: 340-345, 1979.
18. Watson, S A , Morns, T. M , Robinson, G., Crimmin, M. J., Brown, P. D., and Hardcastle, J D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models Cancer Res. 55. 3629-3633, 1995.
19. Naito, K , Kanbayashi, N., Nakajima, S , Murat, T., Arakawa, K., Nishimura S., and Okuyama, A. Inhibiton of growth of human tumor cellsinnude mice by a metalloproteinase inhibitor. Int. J. Cancer, 58: 730-735, 1994.
20. Brown, P. D., Kleiner, D. E., Unsworth, E. J., and Steuer-Stevenson, W. G. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int., 43. 163-170, 1993.
21. Nakajima, M , Welch, D R., Belloni, P N., and Nicolson, G. L Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res , 47: 4869-4876, 1987.
22. Moses, M. A , and Langer, R. Metalloproteinase inhibition as a mechanism for the inhibition of angiogenesis. In: R Steiner, P. B. Weisz, and R Langer (eds). Angiogenesis: Key Principles-Science-Technology-Medicine. Basel, Switzerland: Birkhauser Verlag, 1992.
23. Marphy, A. N., Unsworth, E. J., and Stetler-Stevenson, W. G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endoihelial cell proliferation. J Cell Physiol., 157: 351-358, 1993.
24. Taraboletti, G., Garofalo, A , Belotti, D., Drudis, T , Borsotti, P , Scanziani, E., Brown, P. D., and Giavazzi, R. Inhibition of angiogenesis and murine hemangioma growth by Batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Natl Cancer Inst , 87: 293-298, 1995.
25. Reich, R., Thompson, E. W., and Iwamoto, Y. Effects of inhibitors of plasminogen activator, serine proteases and collagenase IV on the invasion of basement membranes by metastatic cells Cancer Res , 48: 3307-3312, 1988.
26. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C , Morris, V. L , Chambers, A F, and Groom, A. C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res., 54: 4791-4797, 1994.
27. Wang, X., Fu, X., Brown, P. D., Crimmin, M. J., and Hoffman, R M Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice Cancer Res., 54: 4726-4728, 1994.
28. Davies, B , Brown, P. B., East, N., Crimmin, M. J., and Balkwill, F. R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts Cancer Res., 53: 2087-2091, 1993.
29. Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Steuer-Stevenson, W. G. Immunohistochemical distribution of type IV collagenaseinnormal, benign and malignant breast tissue. Am. J. Pathol., 136: 585-592, 1990.
30. Andersson, L. M., Dundas, S R., O'Hare, M J., Gusterson, B. A , and Warburton, M. J. Synthesis of gelatinases by rat mammary epithelial and myoepithelial cell lines. Exp. Cell Res., 212: 389-392, 1994.
31. Sato, H , Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto. E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
32. r 72000 type IV collagenase. Cancer Res , 52. 5845-5848, 1992.
33. Azzam, H. S , Arand, G., Lippman, M. E., and Thompson, E. W. Association of MMP-2 activation potential with metastatic progressioninhuman breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. 85: 1758-1764, 1993.
34. Noel, A. C , Polette, M., Lewalle, J-M , Munaut, C., Emonard, H. P., Birembaut, P., and Foidart, J M Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast adenocarcinoma cells. Int. J. Cancer, 56: 331-336, 1994.
35. Polette, M , Gilbert, N., Stas, I , Nawrocki, B , Noel, A., Remade, A., Stetler-Stevenson, W G , Birembaut, P , and Foidart, M. Gelatinase A expression and localization in human breast cancers: an in situ hybridization study and immunohistochemieal detection using confocal microscopy Virchows Arch., 424: 641-645, 1994
36. Barnett, S. C., and Eccles, S. A. Studies of mammary carcinoma metastasis in a mouse model system 1 Derivation and characterization of cells with different metastatic properties during tumor progression in vivo Clin. Exp. Metastasis, 2: 15-36, 1984.
37. Thompson, E W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G , Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150: 534-554, 1992.
38. Sommers, C. L , Heckford, S. E., Sherker, J. M., Worland, P , Tom, J A , Thompson, E. W., Byers, S W., and Gelman, E. P. Loss of epithelial markers and acquisition of vimentin expression in Adriamycin- and vinblastin-resistant human breast cancer cell lines. Cancer Res., 52: 5190-5197, 1992
39. Nakanishi, H., Taylor, R. M , Chrest, F. J., Masui, T., Utsumi, K., Tatematsu, M., and Passaniti, A. Progression of hormone-dependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal spontaneous rat mammary tumor cell line. Cancer Res , 55: 399-407, 1995.
40. Thompson, E. W., Torri, J., Sabol, M., Sommers, C L., Byers, S , Valverius, E M , Martin, G R., Lippman, M. E., Stampfer, M R., and Dickson, R. B Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis, 12: 181-194, 1994
41. Raymond, W. A., and Leong, A S-Y. Vimentin-a neu prognostic parameter in breast carcinoma? J. Pathol., 158: 107-114, 1989
42. Domagala, W., Lasota, J., Bartowiak, J., Weber, K , and Osborne, M Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki67 growth fraction. Am. J. Pathol., 136: 219-227, 1990.
43. Jouanneau, J., Gavrilovic, J., Caruelle, D , Jaye, M., Moens, G., Caruelle, J-P., and Thiery, J. P. Secreted or non-secreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility and invasive potential Proc. Natl. Acad. Sci USA, 88: 2893-2897, 1991
44. Brown, P. D., and Giavazzi, R. Matrix metalloproteinase inhibition: a review of anti-tumor activity Ann. Oncol., in press, 1995.
45. Kohn, E. C., and Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55: 1856-1862, 1995.